A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Senseonics Holdings, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 396,600 shares of SENS stock, worth $158,640. This represents 0.0% of its overall portfolio holdings.

Number of Shares
396,600
Previous 912,100 56.52%
Holding current value
$158,640
Previous $520,000 59.42%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$0.5 - $0.73 $257,750 - $376,315
-515,500 Reduced 56.52%
396,600 $211,000
Q4 2023

Feb 13, 2024

BUY
$0.48 - $0.7 $437,808 - $638,470
912,100 New
912,100 $520,000
Q2 2023

Aug 11, 2023

BUY
$0.55 - $0.89 $978,694 - $1.58 Million
1,779,445 New
1,779,445 $1.36 Million
Q3 2022

Nov 14, 2022

BUY
$1.02 - $2.23 $1.31 Million - $2.87 Million
1,285,888 Added 221.06%
1,867,588 $2.47 Million
Q2 2022

Aug 12, 2022

BUY
$0.94 - $1.94 $103,024 - $212,624
109,600 Added 23.22%
581,700 $599,000
Q1 2022

May 13, 2022

SELL
$1.54 - $3.71 $2.89 Million - $6.95 Million
-1,873,400 Reduced 79.87%
472,100 $930,000
Q4 2021

Feb 11, 2022

SELL
$2.58 - $3.91 $13.1 Million - $19.9 Million
-5,077,500 Reduced 68.4%
2,345,500 $6.26 Million
Q3 2021

Nov 12, 2021

BUY
$2.77 - $4.05 $4.64 Million - $6.79 Million
1,676,173 Added 29.17%
7,423,000 $25.2 Million
Q2 2021

Aug 13, 2021

BUY
$1.71 - $4.14 $6.77 Million - $16.4 Million
3,958,327 Added 221.32%
5,746,827 $22.1 Million
Q1 2021

May 13, 2021

BUY
$0.85 - $5.27 $648,550 - $4.02 Million
763,000 Added 74.4%
1,788,500 $4.72 Million
Q4 2020

Feb 10, 2021

BUY
$0.36 - $0.95 $346,164 - $913,490
961,569 Added 1504.07%
1,025,500 $894,000
Q3 2020

Nov 13, 2020

BUY
$0.36 - $0.53 $23,015 - $33,883
63,931 New
63,931 $25,000

Others Institutions Holding SENS

About Senseonics Holdings, Inc.


  • Ticker SENS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 465,447,008
  • Market Cap $186M
  • Description
  • Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...
More about SENS
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.